High-Dose Insulin Euglycaemic Therapy in Severe Calcium Channel Blocker Overdose Presenting as Refractory Shock: A Case Report
International Journal of Drug Delivery Technology · 09.04.2026 · 16 (6s)
DOI: 10.25258/ijddt.16.6s.28 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 09.04.2026. Verfasst von Dr. Haneena Haneef und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Background: Shock refractory to standard resuscitative measures represents a medical emergency and should prompt evaluation for uncommon etiologies, including toxicological causes. Calcium channel blocker (CCB) overdose is associated with high morbidity and mortality due to severe myocardial depression, vasodilation, metabolic derangements, and multiorgan dysfunction. Early recognition and targeted therapy are crucial for survival. Case Presentation: A 26-year-old female who presented with nausea, vomiting, and giddiness following intentional ingestion of large quantities of sustained-release diltiazem and amlodipine. On admission, she was profoundly hypotensive with metabolic acidosis, hyperglycemia, and new-onset atrial fibrillation. Despite aggressive initial management with intravenous fluids, calcium supplementation, glucagon, and maximal vasopressor support, the patient remained in refractory shock. Her clinical course was complicated by oliguria, respiratory compromise, pleural effusions, and worsening metabolic abnormalities. Two cycles of hemoperfusion were performed as adjunctive therapy. In view of persistent hemodynamic instability, high-dose insulin euglycaemic therapy (HIET) was initiated and titrated to high infusion rates with concurrent dextrose supplementation. Following initiation of HIET, the patient demonstrated sustained hemodynamic improvement, resolution of metabolic acidosis, and recovery of end-organ function. Vasopressors were successfully tapered, respiratory support was discontinued, and the patient was discharged with complete functional recovery. This case highlights the importance of considering CCB overdose in patients presenting with refractory shock and emphasizes the pivotal role of high-dose insulin euglycaemic therapy as an effective, life-saving treatment in severe CCB toxicity
Zitieren
APA
Haneef, D. H., Udapudi, D. S. V., pawar, D. A., A, D. A. A., Hatti, D. M. A., C, D. A. T., M, D. L., A, D. M. U., S, D. J. K., & Joji, D. S. (2026). High-Dose Insulin Euglycaemic Therapy in Severe Calcium Channel Blocker Overdose Presenting as Refractory Shock: A Case Report. International Journal of Drug Delivery Technology, 16(6s). https://doi.org/10.25258/ijddt.16.6s.28
Vancouver
Haneef DH, Udapudi DSV, pawar DA, A DAA, Hatti DMA, C DAT, et al. High-Dose Insulin Euglycaemic Therapy in Severe Calcium Channel Blocker Overdose Presenting as Refractory Shock: A Case Report. International Journal of Drug Delivery Technology. 2026;16(6s). doi:10.25258/ijddt.16.6s.28
BibTeX
@article{Haneef2026,
author = {Haneef, Dr. Haneena and Udapudi, Dr Shailesh V and pawar, Dr Ajay and A, Dr Afsal Ahmed and Hatti, Dr Mahesh A and C, Dr Anas T and M, Dr Lakshmi. and A, Dr Mohammed Unais and S, Dr Jishnu K and Joji, Dr Sneha},
title = {High-Dose Insulin Euglycaemic Therapy in Severe Calcium Channel Blocker Overdose Presenting as Refractory Shock: A Case Report},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {6s},
doi = {10.25258/ijddt.16.6s.28}
}
EUVIMED